Riskpilot← Back to searchSign inGet full accessVanadis Diagnostics AB
ABActiveOrg 5569493728Vetenskapsvägen 10Research and experimental development on natural sciences and engineering · NACE 7210Est. 201324 employees
Revenue 2024
SEK 37,4M
-44% vs 2023
EBITDA margin
8.5%
-81% vs 2023
Equity ratio
93.2%
Financial strength
Net profit 2024
SEK 458K
-97% vs 2023
| Revenue | SEK 37,4M | -44% |
| EBITDA | SEK 3,2M | -81% |
| Net profit | SEK 458K | -97% |
| Total assets | SEK 52,1M | -73% |
| Equity | SEK 48,6M | -74% |
| Employees | 24 | — |
Legal name
Vanadis Diagnostics AB
Org number
5569493728
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
19 november 2013
Share capital
SEK 141 000
Employees
24 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna externa firmatecknarna
Company purpose
Bolaget skall bedriva produktion, handel och försäljning av produkter för genetisk analys och diagnostik samt därmed förenlig verksamhet.
Address
Vetenskapsvägen 10
Phone
+46840805956
Email
info@vanadisdx.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 102 433 | 89 601 | 91 777 | 67 013 | 37 386 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 5 661 | −3 929 | 4 200 | 16 844 | 3 181 |
| Depreciation & amort. | −7 311 | −7 187 | −4 972 | −2 536 | −2 502 |
| EBIT | −1 650 | −11 116 | −772 | 14 308 | 679 |
| Net financials | 734 | 759 | 1 376 | 1 897 | −22 |
| Profit before tax | −916 | 2 485 | 33 604 | 16 204 | 658 |
| Tax | −0 | −0 | −0 | −2 800 | −200 |
| Net profit | −916 | 2 485 | 33 604 | 13 404 | 458 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 217 912 | 220 657 | 249 440 | 194 934 | 52 147 |
| Equity | 198 671 | 201 156 | 234 759 | 188 164 | 48 622 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 19 241 | 19 501 | 14 681 | 6 770 | 3 525 |
| Total debt | 19 241 | 19 501 | 14 681 | 6 770 | 3 525 |
EBITDA margin
8.5%
This company
15.8%
Market median
-46% vs market
20202024
Equity ratio
93.2%
This company
38.2%
Market median
+144% vs market
20202024
Return on equity
0.9%
This company
18.4%
Market median
-95% vs market
20202024
Net profit margin
1.2%
This company
8.1%
Market median
-85% vs market
20202024
Asset turnover
0.72×
This company
1.12×
Market median
-36% vs market
20202024
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
ÅA External Signatory | External Signatory | 2025 |
BE Chief Auditor | Chief Auditor | 2022 |
BF External Signatory | External Signatory | 2024 |
| Former (3) | ||
PG Authorized Recipient of Service | Authorized Recipient of Service | 2022 – 2024 |
KL Chief Auditor | Chief Auditor | 2020 – 2022 |
JO Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Chairman | 2025 | |
| Board of Directors | 2020 | |
| Former (2) | ||
| Chairman | 2020 – 2025 | |
| Board of Directors | 2020 – 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
REVVITY HOLDING LUXEMBOURG SRL
Vanadis Diagnostics AB Board members of Vanadis Diagnostics AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per-Ola Gustav Forsgren | Authorized Recipient of Service | 0 companies |
| Åsa Anna Maria Janfalk Carlsson | External Signatory | 0 companies |
| Karl Leonard Daun | Chief Auditor | 0 companies |
| Bengt Eric Patric Kruse | Chief Auditor | 0 companies |
| Bo Fredrik Gabriel Åhbeck | External Signatory | 0 companies |
| John Olof Ericsson | Chief Executive Officer | 0 companies |
| Malak Benyakhlef | Board of Directors | 0 companies |
| Antonio Castillo Espinosa | Chairman | 0 companies |
| John Leo Healy | Chairman | 0 companies |
| Massimo Maggioni | Board of Directors | 0 companies |
| Dennis Martin Flannelly | Board of Directors | 0 companies |